Skip to content
10-Q/A

Quarterly Report

AEOLUS PHARMACEUTICALS, INC.

0001102624-16-002806

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · May 16, 2016 151.56M sh
Stockholders Equity Q2 2016 · Mar 31, 2016 $5.02M
Stockholders Equity Q2 2016 · Sep 30, 2015 −$845K
Current Liabilities Q2 2016 · Mar 31, 2016 $1.24M
Current Liabilities Q2 2016 · Sep 30, 2015 $2.62M
Total Liabilities Q2 2016 · Mar 31, 2016 $1.24M
Total Liabilities Q2 2016 · Sep 30, 2015 $2.62M
Current Assets Q2 2016 · Mar 31, 2016 $6.23M
Current Assets Q2 2016 · Sep 30, 2015 $1.75M
Total Assets Q2 2016 · Mar 31, 2016 $6.26M
Total Assets Q2 2016 · Sep 30, 2015 $1.78M
Shares Diluted Q2 2016 · Mar 31, 2015 135.85K sh
Shares Diluted Q2 2016 · Mar 31, 2015 135.85K sh
Operating Cash Flow Q2 2016 · Mar 31, 2015 −$1.27M
Cash And Equivalents Q2 2016 · Mar 31, 2015 $248K
Cash And Equivalents Q2 2016 · Sep 30, 2014 $1.52M
Eps Diluted Q2 2016 · Mar 31, 2015 −$0.01
Eps Diluted Q2 2016 · Mar 31, 2015 −$0.01
Eps Basic Q2 2016 · Mar 31, 2015 −$0.01
Eps Basic Q2 2016 · Mar 31, 2015 −$0.01
Sga Expense Q2 2016 · Mar 31, 2015 $604K
Sga Expense Q2 2016 · Mar 31, 2015 $1.25M
Rd Expense Q2 2016 · Mar 31, 2015 $1.3M
Rd Expense Q2 2016 · Mar 31, 2015 $2.27M
Net Income Q2 2016 · Mar 31, 2015 −$712K
Net Income Q2 2016 · Mar 31, 2015 −$1.41M
Operating Income Q2 2016 · Mar 31, 2015 −$712K
Operating Income Q2 2016 · Mar 31, 2015 −$1.41M